NFKB1 and type 2 diabetes mellitus: have shown that berberine alleviates lipopolysaccharide (LPS)-induced β-cell inflammation and apoptosis by blocking TLR4 signaling and the downstream JNK/NF-κB pathway (122), which is closely related to the inflammation and β-cell dysfunction in T2DM (122).